1L Cemiplimab in Adv NSCLC With Liver Mets
Phase III EMPOWER-Lung 1 and 3: Updated Long-term Subgroup Analysis of Cemiplimab in Newly Diagnosed Advanced NSCLC With Liver Metastases

Released: September 19, 2023

Activity

Progress
1
Course Completed